Current topics in medicinal chemistry最新文献

筛选
英文 中文
Recent Synthetic Advancement and Medicinal Applications of Asymmetric Cyclic Pyrazoline-based Hydrazine Derivatives: A Review. 不对称环吡唑啉类联氨衍生物的合成进展及医药应用综述
IF 2.9 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-04-30 DOI: 10.2174/0115680266374814250422053723
Dattatraya Raut, Raghunath Bhosale, Dnyandev Bhosale, Anjana Lawand, Mahesh Hublikar
{"title":"Recent Synthetic Advancement and Medicinal Applications of Asymmetric Cyclic Pyrazoline-based Hydrazine Derivatives: A Review.","authors":"Dattatraya Raut, Raghunath Bhosale, Dnyandev Bhosale, Anjana Lawand, Mahesh Hublikar","doi":"10.2174/0115680266374814250422053723","DOIUrl":"https://doi.org/10.2174/0115680266374814250422053723","url":null,"abstract":"<p><p>Chemistry research focuses on reducing energy and minimizing harmful byproducts. Pyrazoline and its derivatives have various pharmacological properties. This study aims to compile procedures for creating pyrazoline scaffolds from academic articles and online resources, such as Scopus, Google Scholar, Web of Science, Science Direct, Research Gate and libraries, aiming to minimize environmental and human health impacts. The primary objective is to determine the structural modifications and chemical groups that enhance their bioactivity, low toxicity, and handling. Furthermore, the review explores the bioavailability, synthetic challenges, and progress made in utilising pyrazoline derivatives in pharmaceutical and synthetic organic chemistry. The only goal is to provide insight into the creation of pyrazoline hybrid molecules that are very effective and less hazardous.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143973567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Designing 1,4-Dihydropyridines-Based Multitarget Therapeutics: Recent Advances and Future Directions. 设计基于1,4-二氢吡啶的多靶点疗法:最新进展和未来方向。
IF 2.9 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-04-30 DOI: 10.2174/0115680266375345250414050338
Aditi Soni, Monika Sharma, Rajesh K Singh
{"title":"Designing 1,4-Dihydropyridines-Based Multitarget Therapeutics: Recent Advances and Future Directions.","authors":"Aditi Soni, Monika Sharma, Rajesh K Singh","doi":"10.2174/0115680266375345250414050338","DOIUrl":"https://doi.org/10.2174/0115680266375345250414050338","url":null,"abstract":"<p><strong>Background: </strong>1,4-Dihydropyridines (1,4-DHPs) serve as versatile scaffolds in medicinal chemistry, exhibiting multitarget potential with anticancer, cardiovascular, antioxidant, antiinflammatory, antimicrobial, and analgesic effects. Structural modifications enhance their binding affinity, bioavailability, and selectivity.</p><p><strong>Aim: </strong>This review aims to explore the broad therapeutic potential of 1,4-DHPs by analyzing their biological activities and structure-activity relationships (SAR). Additionally, it seeks to provide medicinal chemists with insights into key structural modifications that can optimize their pharmacological efficacy.</p><p><strong>Method: </strong>A comprehensive literature search was conducted in PubMed, ScienceDirect, Elsevier, and Google Scholar, prioritizing peer-reviewed studies from the last decade. Inclusion criteria focused on pharmacological properties, SAR, and therapeutic potential of 1,4-DHPs, while nonpeer- reviewed or irrelevant studies were excluded. Data extraction analyzed SAR trends, emphasizing the impact of structural modifications on binding affinity, bioavailability, and biological activity.</p><p><strong>Results: </strong>The review highlights that specific modifications in aromatic substituents, ester groups, and heterocyclic rings play a crucial role in enhancing the biological activity and selectivity of 1,4- DHPs. Their ability to modulate key enzymes and receptors contributes to their effectiveness as multitarget agents. Comparative SAR analysis provides evidence of the potential of 1,4-DHPs as next-generation therapeutics.</p><p><strong>Conclusion: </strong>1,4-DHPs offer a promising framework for drug development, with the potential to address complex, multifactorial diseases. By understanding and optimizing SAR, medicinal chemists can design more selective and potent 1,4-DHP-based drugs. Future research should focus on refining these structural modifications to unlock their full therapeutic potential.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143986538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioactive Compound Chemistry and Antiasthmatic Activity of Betulinic Acid and Taraxerol in Experimental Models. 实验模型中白桦酸和Taraxerol的生物活性化合物化学及平喘活性。
IF 2.9 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-04-30 DOI: 10.2174/0115680266358488250421012523
Shiv Narayan, Gaurav Krishna, Raghav Mishra
{"title":"Bioactive Compound Chemistry and Antiasthmatic Activity of Betulinic Acid and Taraxerol in Experimental Models.","authors":"Shiv Narayan, Gaurav Krishna, Raghav Mishra","doi":"10.2174/0115680266358488250421012523","DOIUrl":"10.2174/0115680266358488250421012523","url":null,"abstract":"<p><strong>Background: </strong>The natural molecules betulinic acid (BA) and taraxerol (T) have many biological and therapeutic uses, one of which is the relief from asthma symptoms. This study wasThis study aimed to assess BA and T effectiveness in treating bronchial asthma and perform a molecular docking study to find the binding energy of BA and T with β-adrenoceptor.</p><p><strong>Methods: </strong>Using ethanol as the solvent, the Bacopa monnieri leaves were extracted using a soxhlet equipment. As a reference medicine, budesenoid was utilised. With PyRx 0.8, the molecular docking experiment was conducted using AutoDock vina. The protocol followed by the acute toxicity study was the OECD guideline 425. The effectiveness of the test medication in alleviating asthma was determined using an anaphylactic microshock model in guinea pigs.</p><p><strong>Results: </strong>Molecular docking analysis showed high binding affinities of BA (-7.95 kcal/mol) and T (-8.23 kcal/mol) to LOX-5, which could suppress the synthesis of leukotriene, one of the central mediators of asthma pathogenesis. In vivo study, the BA and T treatment prolonged pre-convulsion time in guinea pigs up to 506.66 seconds as compared with the control (406.6 seconds, p < 0.05). This suggests protection against bronchial hyperresponsiveness. ELISA assays demonstrated that BA and T decreased the levels of TNF-α and increased IL-10, indicating a potential modulation of inflammation (p < 0.05). Markers of oxidative stress were lowered in treated animals, as demonstrated by the lowered MDA and enhanced activities of antioxidant enzymes such as SOD, CAT, and GSH, suggesting a protective effect against oxidative lung damage (p < 0.05). Histological analysis confirmed a decrease in inflammatory cell infiltration and airway remodeling in the treated groups compared to the OVA-induced controls.</p><p><strong>Conclusion: </strong>The results of the animal studies showed that BA and T reduced anaphylaxis, suggesting that it could be a viable alternative to current asthma treatments in the future. The results of the molecular docking investigation, however, showed that BA and T may indeed bind to the target receptor, opening the door to new treatment possibilities.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143986131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Plasma Exosomes of Young Individuals Compared to Old Ones on Age-Related Inflammation and Lineage Differentiation of CD34+ Umbilical Cord Blood Hematopoietic Stem Cells. 与老年人相比,年轻人血浆外泌体对年龄相关炎症和CD34+脐血造血干细胞谱系分化的影响
IF 2.9 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-04-30 DOI: 10.2174/0115680266361607250418052405
Maryam Helali, Saeid Kaviani, Shaban Alizadeh, Reza Afrisham, Mohammad Ahmadvand
{"title":"The Effects of Plasma Exosomes of Young Individuals Compared to Old Ones on Age-Related Inflammation and Lineage Differentiation of CD34+ Umbilical Cord Blood Hematopoietic Stem Cells.","authors":"Maryam Helali, Saeid Kaviani, Shaban Alizadeh, Reza Afrisham, Mohammad Ahmadvand","doi":"10.2174/0115680266361607250418052405","DOIUrl":"10.2174/0115680266361607250418052405","url":null,"abstract":"<p><strong>Introduction: </strong>Cellular aging is a complicated event known for gradually reducing homeostasis, leading to a higher susceptibility to diseases and mortality. Since the behavior of Hematopoietic Stem Cells (HSCs) is potentially affected by plasma-derived exosomes, this study aimed to investigate whether the plasma-derived exosome of young and elderly human donors can deliver \"youth\" or \"aging\" signals into human umbilical cord blood-derived HSCs in vitro.</p><p><strong>Methods: </strong>Exosomes were isolated from four young (Y-exo) and four old (O-exo) donors. Umbilical cord blood-derived HSCs were exposed to two concentrations of exosomes (5 and 10 μg/mL). Then, lineage differentiation (CD41 and CD38), the mRNA and protein expression of IL-1β and IL- 6, and NFκB activity were evaluated using flow cytometry, qRT-PCR Enzyme-Linked Immunosorbent Assay (ELISA) methods, and western blot techniques, respectively.</p><p><strong>Results: </strong>The lineage-specific markers CD41 and CD38 expression were increased after exposure to O-exo compared to Y-exo at the concentration of 10 μg/mL (P<0.001). The HSCs treated with 10 μg/mL O-exo increased protein and mRNA expression of IL-1β and IL-6 compared to Y-exo at 10 μg/mL concentration (P<0.01). Furthermore, a significant difference was seen in p-NF-κB levels between O-exo and Y-exo at the concentration of 10 μg/mL (P=0.0014).</p><p><strong>Conclusion: </strong>Our findings advocated the concept that circulating exosomes of old and young individuals may differently affect the pathways involved in the aging process in HSCs.Therefore, exosomes may be applied as therapeutic agents for regenerative medicine.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143957235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Organoid Culture Systems in Pancreatic Cancer. 当前胰腺癌类器官培养系统。
IF 2.9 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-04-29 DOI: 10.2174/0115680266392238250423115420
Lei Liu, Jing Sun, Sheng Chen, Xuechan Tang, Shuai Zhang, Min Wang, Qian Yue, Changqing Zhong, Lianyong Li
{"title":"Current Organoid Culture Systems in Pancreatic Cancer.","authors":"Lei Liu, Jing Sun, Sheng Chen, Xuechan Tang, Shuai Zhang, Min Wang, Qian Yue, Changqing Zhong, Lianyong Li","doi":"10.2174/0115680266392238250423115420","DOIUrl":"https://doi.org/10.2174/0115680266392238250423115420","url":null,"abstract":"<p><p>Despite advances in therapeutic regimens, Pancreatic Cancer (PC) still remains an aggressive malignancy characterized by high treatment resistance, mortality, and poor clinical outcome. Hence, there is an urgent need for more effective therapeutic methods to improve the survival of PC patients. Currently, organoid culture systems have emerged as a preclinical research model for studying cancer progression, biology, and treatment responses, bridging the translational gap between in vivo and in vitro models. This review summarized the common culture systems of PC organoids, paving the way for precision medicine in PC.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143976921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence-Driven Innovations in Pharmaceutical Development and Drug Delivery Systems. 药物开发和药物输送系统中的人工智能驱动创新。
IF 2.9 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-04-24 DOI: 10.2174/0115680266373236250411060857
Ting Zhu, Bing Liu, Ning Chen, Yuchen Liu, Zixuan Wang, Xue Tian
{"title":"Artificial Intelligence-Driven Innovations in Pharmaceutical Development and Drug Delivery Systems.","authors":"Ting Zhu, Bing Liu, Ning Chen, Yuchen Liu, Zixuan Wang, Xue Tian","doi":"10.2174/0115680266373236250411060857","DOIUrl":"https://doi.org/10.2174/0115680266373236250411060857","url":null,"abstract":"<p><p>As Artificial Intelligence (AI) technology rapidly advances, its application in pharmaceutical formulation design and Drug Delivery Systems (DDS) is expanding, revealing significant potential. AI technology has played a role in optimizing drug design, enhancing research and development efficiency, and improving the safety profiles of pharmaceutical products, thereby supporting the realization of personalized medicine. This article systematically examines the foundational applications and principles of AI in pharmaceutical formulation, while also evaluating its role in key areas such as drug development, manufacturing, quality control, and ADME/T (absorption, distribution, metabolism, excretion, and toxicity) prediction. In particular, AI can enhance prediction accuracy for drug solubility, stability, and bioavailability, while optimizing novel DDS through Machine Learning (ML) models, such as nanocarrier design and personalized drug release control. Furthermore, AI has been pivotal in advancing intelligent manufacturing technologies, including three-dimensional printing (3D printing) and continuous manufacturing. Finally, the article explores the opportunities and challenges presented by AI in drug development, regulation, and policymaking. Overall, AI's integration promises to revolutionize pharmaceutical development and regulatory practices.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144062661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanoencapsulation of Essential Oil: A Tailored System of Green Therapeutic Potential. 精油的纳米胶囊化:一种具有绿色治疗潜力的定制系统。
IF 2.9 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-04-24 DOI: 10.2174/0115680266342801250303004033
Shefali Arora, Sukanya Chhetri, Pankaj Bhandari
{"title":"Nanoencapsulation of Essential Oil: A Tailored System of Green Therapeutic Potential.","authors":"Shefali Arora, Sukanya Chhetri, Pankaj Bhandari","doi":"10.2174/0115680266342801250303004033","DOIUrl":"https://doi.org/10.2174/0115680266342801250303004033","url":null,"abstract":"<p><p>Essential oils (EOs) are at the forefront of the pharmaceutical industry today and have been rekindled as natural drugs with innovative techniques. However, many factors related to their volatility and deterioration can be captured by encapsulation. The nanoencapsulation of EO is a novel development to protect EOs from environmental factors in order to retain their biochemical and pharmacological properties, thus leading toward sustainable health advancement. Nanoencapsulation of essential oil (EO) is a fascinating technique to solve the instability problem of EOs in the presence of light, air, moisture, and temperature variations. In addition to this, this process ensures safer handling with controlled release, along with improved efficacy and bioavailability. This review outlines the most outstanding methods for the nanoencapsulation of EOs and their mechanism of action against disease pathogenesis.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143983240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements in Herbal Drug Loaded Nanoparticulate System for Antimicrobial Effect. 载药纳米颗粒抗菌系统的研究进展。
IF 2.9 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-04-23 DOI: 10.2174/0115680266366494250411164750
Anjali Rana, Arun Mittal, Chetan Vashist, Shivam Rajput, Sathvik Belagodu Sridhar, Sangeet Sharma, Rishabha Malviya
{"title":"Advancements in Herbal Drug Loaded Nanoparticulate System for Antimicrobial Effect.","authors":"Anjali Rana, Arun Mittal, Chetan Vashist, Shivam Rajput, Sathvik Belagodu Sridhar, Sangeet Sharma, Rishabha Malviya","doi":"10.2174/0115680266366494250411164750","DOIUrl":"https://doi.org/10.2174/0115680266366494250411164750","url":null,"abstract":"<p><p>Herbal medicinal compounds have fewer side effects than modern drugs. Herbal materials are primary medicines and have strong antibacterial characteristics, thus most people throughout the world utilize them. Poor solubility, low bioavailability, instability in the biological environment, and substantial first-pass metabolism are some of the challenges associated with delivering plant/herbal medicinal compounds as pharmaceuticals. The use of appropriate nanotechnology for attachment or encapsulation can circumvent these drawbacks of herbal medications. To efficiently administer herbal medications, nanoparticulate formulations such as microemulsions, solid lipid nanoparticles, polymeric nanoparticles, liposomes, and proliposomes are being considered. This article aims to effectively examine the ability of herbal drugs that contain NP to combat microorganisms as well as a variety of herbal plants with antibacterial properties, including thyme, clove, garlic, mallow, chamomile, and mentha pulegium. This comprehensive analysis is timely and necessary since nanotechnology is a promising prospect in infectious disease treatment. Additionally, recent advances in producing herbal medicine formulations based on nanoparticle technologies are also summarised in this review article.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143972506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Superbug Neisseria gonorrhoeae Infections: The Role of the Moonlighting Protein Glutamate Racemase in Treatment and Prevention. 超级细菌淋病奈瑟菌感染:月光蛋白谷氨酸消旋酶在治疗和预防中的作用。
IF 2.9 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-04-23 DOI: 10.2174/0115680266365593250415101135
Sujata Adhana, Ravi Jain, Sibasis Sahoo, Sheetal Thakur, Archna Pandey, Avneesh Mittal, Bishwajit Kundu, Uma Chaudhry
{"title":"Superbug Neisseria gonorrhoeae Infections: The Role of the Moonlighting Protein Glutamate Racemase in Treatment and Prevention.","authors":"Sujata Adhana, Ravi Jain, Sibasis Sahoo, Sheetal Thakur, Archna Pandey, Avneesh Mittal, Bishwajit Kundu, Uma Chaudhry","doi":"10.2174/0115680266365593250415101135","DOIUrl":"https://doi.org/10.2174/0115680266365593250415101135","url":null,"abstract":"<p><strong>Introduction: </strong>Neisseria gonorrhoeae is a notorious superbug responsible for causing 'Gonorrhoea' in humans. Recently, it has been classified as a high-priority pathogen by the World Health Organization due to its increasing resistance to available antibiotics. A multi-prolonged approach is needed to combat the growing problem of drug resistance caused by N. gonorrhoeae. This study evaluates Glutamate Racemase (GR), a moonlighting protein of N. gonorrhoeae (Ng- GR), as a novel therapeutic target with potential for both inhibitor design and peptide vaccine development. Ng-GR plays a crucial role in the peptidoglycan biosynthetic pathway and is highly conserved across bacterial species. Additionally, this protein moonlights to perform a secondary function by binding to DNA gyrase in various organisms.</p><p><strong>Method: </strong>Homology modeling, molecular docking, and molecular dynamics simulations were used to design inhibitors targeting the moonlight function of Ng-GR. The immunogenicity of this protein was assessed using ABCPred-2.0, BepiPred-2.0, and ProPred software.</p><p><strong>Results: </strong>Bisleucocurine A was found to bind at the ectopic site of Ng-GR, disrupting its crucial moonlight function and interfering with the interaction between Ng-GR and N. gonorroheae DNA Gyrase (Ng-gyrase). Interestingly, residues important for its moonlight function were also identified as key immunogenic sites using ABCPred-2.0, BepiPred-2.0, and ProPred software, enhancing the potential of this protein as a vaccine candidate.</p><p><strong>Conclusion: </strong>The GR enzyme's moonlight function is highlighted as a promising novel target for therapeutic intervention and vaccine development in N. gonorrohoeae.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143984885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phytomolecules from Herbs: Possible Effective Way for the Treatment of Liver Cancer. 草药植物分子:治疗肝癌的可能有效途径。
IF 2.9 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-04-21 DOI: 10.2174/0115680266321814250228070642
Sweta Mohan, Anupam Maurya, Raman Mohan Singh
{"title":"Phytomolecules from Herbs: Possible Effective Way for the Treatment of Liver Cancer.","authors":"Sweta Mohan, Anupam Maurya, Raman Mohan Singh","doi":"10.2174/0115680266321814250228070642","DOIUrl":"https://doi.org/10.2174/0115680266321814250228070642","url":null,"abstract":"<p><p>Liver cancer is the sixth most commonly diagnosed cancer globally, accounting for approximately 50% of all diagnosed cases and associated mortalities. The principal therapeutic strategies for liver cancer presently include surgical intervention, radiotherapy, and laser ablation therapies. All these therapies are effective for liver cancer at an early stage and have limited efficacy for advanced-stage cancer due to severe side effects and drug resistance. The plantderived natural product, i.e. phyto-constituents, has been evaluated as a potential anticancer drug due to low side effects and antitumor efficacy. Many studies support the effectiveness of active phytoconstituents found in various plants such as garlic, turmeric, tomatoes, grapes, pomegranates, plums, black currants, French beans, cruciferous vegetables, ginger, and asparagus. These plants are reported to have very diversified groups of compounds such as alkaloids, flavonoids, phenolics, terpenoids, coumarin, etc., attributed to medicinal values and biological activities such as antiviral, antioxidant, anti-inflammatory, anticancer, etc. These plants provide important nutrients and help to maintain health, thereby reducing the risk of disease. Almost 50 drugs are directly or indirectly derived from natural sources because of minimum side effects and diversified chemical compounds. In this review, the anticancer properties of edible plants-derived phytomolecules, such as glycyrrhizin, triptolide, celastrol, berberine hydrochloride, curcumin, stilbenes, etc., against Hepatocellular Carcinoma (HCC) are discussed in detail. Phytomolecules discussed in this review for HCC could be promising leads or drugs as anticancer agents from economical and easily available plant sources.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143962050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信